Cancer Symptom Trials (CST) Annual Research Forum 2020 Event Banner
Cancer Symptom Trials (CST)

Cancer Symptom Trials (CST) Annual Research Forum 2020

Tue 18th Feb 2020, 9:00 am - 4:30 pm


$220 - $275 AUD

$220 - $275 AUD

Cancer Symptom Trials (CST)

Cancer Symptom Trials (CST) Annual Research Forum 2020

Date and Time

Tue 18th Feb 2020, 9:00 am - 4:30 pm
Add to Calendar


Aerial UTS Function Centre
Building 10, Level 7/235 Jones St, Ultimo NSW 2007, Australia

Event description

The Cancer Symptom Trials (CST) Annual Research Forum brings together researchers, health professionals and consumer representatives interested in cancer symptom management and supportive care. 

The theme for the CST Annual Research Forum 2020 is Vision 2030: Cancer Symptom Trials.

The Forum is aimed at anyone interested in cancer symptom management and supportive care clinical trials research. 


The program includes presentations from invited speakers:

Professor Dorothy Keefe will give the opening address. She is the CEO of Cancer Australia and an Honorary Clinical Professor at the University of Adelaide as well as a past-President of the Multinational Association of Supportive Care in Cancer (MASCC). In 2013, she was awarded a Public Service Medal for her service to public health, medical research and oncology.

Professor Vickie Baracos is the keynote speaker. Professor Baracos is a researcher in the Department of Oncology, Division of Palliative Care at the University of Alberta. She has more than 30 years' experience researching the physiology and pathology of cancer-associated wasting of skeletal muscle. Her current research focus is on the measurement of cancer-related muscle wasting using computer tomography. She is a Principal Investigator of a major organised effort to develop clinical cachexia research, Cachexia Network, to provide synergy in knowledge generation and knowledge synthesis across the larger body of research findings, dissemination of findings to specific target groups, engagement strategies to relevant clinical practice communities and scientific communities and training a new cadre of researchers.

Associate Professor Richard De Abreu Lourenco is an Associate Professor with CHERE and Pis currently working as the Project Coordinator for the Cancer Research Economics Support Team (CREST) and as Senior Evaluator for the Pharmaceutical Benefits Advisory Committee (PBAC) team.

Chairs of four symptom node subcommittees will present on their research in management of particular symptoms including appetite and cachexia, pain, fatigue and nausea. 

Additional program information is available on the CST Events page.


Delegates are required to sign a confidentiality agreement. Current members may already have one in place. CST staff will contact you if you need to sign a confidentiality agreement.

Photograph permissions

Photographs will be taken on the day for promotional purposes. 

The University of Technology Sydney has the absolute right of ownership of any photographs taken on the day and will be entitled to publish, distribute and use the images for promotional purposes. 

If you do not wish your photograph to appear in any promotional materials, please email cst@uts.edu.au to advise. 

Refund Policy

Refunds are available 1 month prior to the event

Share event


Cancer Symptom Trials (CST)


Cancer Symptom Trials (CST) is one of fourteen Cancer Cooperative Trials Groups (CCTGs) funded by Cancer Australia. CST is a research collaborative within the Improving Palliative, Aged and Chronic Care through Research and Translation (IMPACCT) research centre at the University of Technology Sydney. Our work is important for the significant number of Australians who are diagnosed with cancer every year. Through our clinical trials, we research options for improved management of symptoms that can occur due to a cancer diagnosis and related treatments. Our goal is to ensure the best quality of life possible for people with cancer. We do this by identifying accessible, affordable, and appropriate medicines and therapies for people with cancer, including those living at home. We acknowledge the significant role that carers play in the lives of people with cancer. They are critical contributors in decisions about management of symptoms. We welcome their inclusion and participation in our research.